These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 7574361)

  • 1. [Experimental models of venous thrombosis].
    Azougagh Oualane F; Doutremepuich F; Doutremepuich C
    Ann Cardiol Angeiol (Paris); 1995; 44(6):288-98. PubMed ID: 7574361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant full-length tissue factor pathway inhibitor (TFPI) prevents thrombus formation and rethrombosis after lysis in a rabbit model of jugular vein thrombosis.
    Kaiser B; Fareed J
    Thromb Haemost; 1996 Oct; 76(4):615-20. PubMed ID: 8903005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of thrombin active site and exosite inhibitors and heparin in experimental models of arterial and venous thrombosis and bleeding.
    Schumacher WA; Steinbacher TE; Heran CL; Seiler SM; Michel IM; Ogletree ML
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1237-42. PubMed ID: 8263785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study of the anticoagulant and anti-thrombotic effects of unfractionated heparin and a low molecular weight heparin (Fraxiparine) in an experimental model of human venous thrombosis.
    Diquélou A; Dupouy D; Cariou R; Sakariassen KS; Boneu B; Cadroy Y
    Thromb Haemost; 1995 Nov; 74(5):1286-92. PubMed ID: 8607111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental studies on venous thrombosis: effect of coagulants, procoagulants and vessel contusion.
    Aronson DL; Thomas DP
    Thromb Haemost; 1985 Dec; 54(4):866-70. PubMed ID: 3879019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention and treatment of experimental thrombosis in rabbits with rivaroxaban (BAY 597939)--an oral, direct factor Xa inhibitor.
    Biemond BJ; Perzborn E; Friederich PW; Levi M; Buetehorn U; Büller HR
    Thromb Haemost; 2007 Mar; 97(3):471-7. PubMed ID: 17334516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A model of venous thrombosis induced by stasis and Feiba in rabbits].
    Tettamanti R; Alberico P; Porta R
    Boll Soc Ital Biol Sper; 1990 May; 66(5):471-8. PubMed ID: 2397109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental thrombosis on a collagen coated arterioarterial shunt in rats: a pharmacological model to study antithrombotic agents inhibiting thrombin formation and platelet deposition.
    Freund M; Mantz F; Nicolini P; Gachet C; Mulvihill J; Meyer L; Beretz A; Cazenave JP
    Thromb Haemost; 1993 May; 69(5):515-21. PubMed ID: 8322274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low affinity heparin is an antithrombotic agent.
    Gray E; Cesmeli S; Lormeau JC; Davies AB; Lane DA
    Thromb Haemost; 1994 Feb; 71(2):203-7. PubMed ID: 8191399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombotic effect of two low molecular weight thrombin inhibitors and a low-molecular weight heparin in a caval vein thrombosis model in the rat.
    Eriksson BI; Carlsson S; Halvarsson M; Risberg B; Mattsson C
    Thromb Haemost; 1997 Nov; 78(5):1404-7. PubMed ID: 9408027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between the sulfated lactobionic acid (LW 10082) and other antithrombotic agents in animal thrombosis model.
    Giedrojć J; Krupiński K; Breddin HK; Bielawiec M
    Pol J Pharmacol; 1996; 48(3):317-22. PubMed ID: 9112669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current trends in antithrombotic drug and device development.
    Fareed J
    Semin Thromb Hemost; 1996; 22 Suppl 1():3-8. PubMed ID: 8807721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of external electrical stimulation on laser-beam-induced experimental thrombosis.
    Aguejouf O; Doutremepuich F; Doutremepuich C
    Pathophysiol Haemost Thromb; 2006; 35(5):364-9. PubMed ID: 17230037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Administration of a small molecule tissue factor/factor VIIa inhibitor in a non-human primate thrombosis model of venous thrombosis: effects on thrombus formation and bleeding time.
    Szalony JA; Suleymanov OD; Salyers AK; Panzer-Knodle SG; Blom JD; LaChance RM; Case BL; Parlow JJ; South MS; Wood RS; Nicholson NS
    Thromb Res; 2003; 112(3):167-74. PubMed ID: 14967414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experimental models of arterial thrombosis].
    Aguejouf O; Imbault P; Jourdan A; Doutremepuich F; Juaneda M; Doutremepuich C
    Ann Cardiol Angeiol (Paris); 1995 Mar; 44(3):109-18. PubMed ID: 7793848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overview of venous thrombogenesis.
    Thomas DP
    Semin Thromb Hemost; 1988 Jan; 14(1):1-8. PubMed ID: 3281261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombotic efficacy of thrombin inhibitor L-374,087: intravenous activity in a primate model of venous thrombus extension and oral activity in a canine model of primary venous and coronary artery thrombosis.
    Cook JJ; Gardell SJ; Holahan MA; Sitko GR; Stump GL; Wallace AA; Gilberto DB; Hare TR; Krueger JA; Dyer DL; Sanderson PE; Vacca JP; Shafer JA; Lynch JJ
    J Pharmacol Exp Ther; 1999 Apr; 289(1):503-10. PubMed ID: 10087043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Additive effect of the combined administration of low molecular weight heparin and recombinant hirudin on thrombus growth in a rabbit jugular vein thrombosis model.
    Biemond BJ; Levi M; Nurmohamed MT; Büller HR; ten Cate JW
    Thromb Haemost; 1994 Sep; 72(3):377-80. PubMed ID: 7855787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SSR182289A enhances thrombolysis induced by fibrinolytic agents in rabbit models of venous and arterial thrombosis.
    Visconte C; Sainte-Marie M; Lorrain J; Millet L; O'Connor SE; Schaeffer P; Herbert JM
    J Thromb Haemost; 2004 Apr; 2(4):629-36. PubMed ID: 15102019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrotic injury after experimental deep vein thrombosis is determined by the mechanism of thrombogenesis.
    Henke PK; Varma MR; Moaveni DK; Dewyer NA; Moore AJ; Lynch EM; Longo C; Deatrick CB; Kunkel SL; Upchurch GR; Wakefield TW
    Thromb Haemost; 2007 Nov; 98(5):1045-55. PubMed ID: 18000610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.